Psychedelic Therapy

Psychedelic therapy, also called psychedelic-assisted therapy, refers to the proposed use of psychedelic drugs such as mescaline, LSD, psilocybin, ayahuasca, DMT, ibogaine and MDMA in mental health treatment practices intended to treat mental disorders and improve well-being. As of the early 2020s psychedelic drugs remained controlled substances in most countries, so psychedelic therapy was not legally available outside clinical trials, with some exceptions. Its procedure differs markedly from that of conventional psychiatric medication: rather than being taken without supervision on a daily basis, the psychedelic drug is administered in a single session, or occasionally up to three sessions, within a therapeutic context in which a therapeutic team prepares the patient for the experience.